Kallyope Stock
HealthTechLooking to sell Kallyope stock or options?
Kallyope operates as a biotechnology firm whose mission is to discover and develop oral agents that are both effective and easy to use. The company employs a combination of technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics. Kallyope's in-depth understanding of gut-brain biology allows it to provide the healthcare sector with therapeutics designed to enhance human health.
William Gates, Bill Gates, Lux Capital, Euclidean Capital, Illumina Ventures, Mubadala Investment Company, The Column Group, Two Sigma Ventures, Illumina, Anthony Evnin, Columbia Technology Ventures, Gates Foundation, DNS Capital, Casdin Capital, Polaris Partners, Alexandria Venture Investments, StepStone Group, Tao Capital Partners.